BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity

Active, not recruiting

Phase 3 Results N/A

Summary of Purpose

This study will evaluate the long-term safety of BOTOX® (botulinum toxin Type A) for the treatment of pediatric upper limb spasticity.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 October 2017.

30 Oct 2012 21 May 2012 1 Aug 2018 1 Aug 2018 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics


Conditions See All


Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment